Does microorganism‑specific antimicrobial prophylaxis reduce the risk of SSI in CD patients undergoing definitive surgery for gastrointestinal fistulas

What is known

- Fistula-output microorganism-susceptible prophylaxis was associated with lower SSI risk in gastrointestinal fistula patients undergoing one-stage definitive surgery. ¹ - Klebsiella pneumoniae colonization within fistula tracts has been described as a risk factor for closure failure, supporting the rationale for organism-directed prophylaxis. ¹ - In a Crohn's SSI cohort, proctectomy was a high-risk factor and preoperative infliximab was not a risk factor for SSI. ²

What is unknown / caveats

- Evidence rests on a single cited retrospective study, not a randomized comparison - No effect size, magnitude, or organism-specific breakdown available in the retrieved chunks - The finding is an association from one study; causal benefit and effect size are not established in the retrieved evidence.

## References

1. Guo K, Ren J, Li G, Hu Q, Wu X, Wang Z, Wang G, Gu G, Ren H, Hong Z, Li J. Risk factors of surgical site infections in patients with Crohn's disease complicated with gastrointestinal fistula. Int J Colorectal Dis. 2017;32(5):635-643. PMID: 28091846.

2. Uchino M, Ikeuchi H, Matsuoka H, Bando T, Ichiki K, Nakajima K, Tomita N, Takesue Y. Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease. Dis Colon Rectum. 2013;56(10):1156-65. PMID: 24022533.

For educational use only — not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

---

_Draft — generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct._